{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:03:50Z","timestamp":1789621430878,"version":"build-2803163510"},"reference-count":17,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1177\/03915603261445157","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:41:19Z","timestamp":1777408879000},"page":"537-538","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on: \u201cComparison of long-term survival for muscle-invasive bladder cancer patients who underwent bladder preservation therapy and radical cystectomy: A systematic review and meta-analysis\u201d"],"prefix":"10.1177","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4640-8354","authenticated-orcid":false,"given":"Emilio","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-9023","authenticated-orcid":false,"given":"Francesco Pio","family":"Bizzarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Warli SM Sihombing B Kadar DD et al. Comparison of long-term survival for muscle-invasive bladder cancer patients who underwent bladder preservation therapy and radical cystectomy: A systematic review and meta-analysis. Urol J 2025; 92: 585\u2013594. https:\/\/doi.org\/10.1177\/03915603251347444","DOI":"10.1177\/03915603251347444"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Fahmy O Khairul-Asri MG Schubert T et al. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urol Oncol 2018; 36(2): 43\u201353. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814391730529X","DOI":"10.1016\/j.urolonc.2017.10.002"},{"key":"e_1_3_2_4_2","unstructured":"Br\u00fcck K Meijer RP Boormans JL et al. Disease-free survival of patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder-preserving therapy: a nationwide study. Int J Radiat Oncol 2024; 118(1): 41\u201349. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623076861"},{"key":"e_1_3_2_5_2","unstructured":"Zlotta AR Ballas LK Niemierko A et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol 2023; 24(6): 669\u2013681. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204523001705"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Totaro A Pinto F Brescia A et al. Imaging in bladder cancer: Present role and future perspectives. Urol Int 2010; 85(4): 373\u2013380. https:\/\/doi.org\/10.1159\/000321279","DOI":"10.1159\/000321279"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Bizzarri FP Nelson AW Colquhoun AJ et al. Utility of fluorodeoxyglucose positron emission tomography\/computed tomography in detecting lymph node involvement in comparison to conventional imaging in patients with bladder cancer with variant histology. Eur Urol Oncol 2025; 8: 1459\u20131460. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000975","DOI":"10.1016\/j.euo.2025.03.019"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Bender R Friede T Koch A et al. Methods for evidence synthesis in the case of very few studies. Res Synth Methods 2018; 9(3): 382\u2013392. https:\/\/doi.org\/10.1002\/jrsm.1297","DOI":"10.1002\/jrsm.1297"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Dahl DM Karrison TG Michaelson MD et al. Long-term outcomes of chemoradiation for muscle-invasive bladder cancer in noncystectomy candidates. Final results of NRG Oncology RTOG 0524-A phase 1\/2 trial of paclitaxel + trastuzumab with daily radiation or paclitaxel alone with daily irradiation. Eur Urol Oncol 2024; 7(1): 83\u201390. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123001153","DOI":"10.1016\/j.euo.2023.05.013"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Gupta S Fujii Y Van Der Heijden MS et al. Phase 3 KEYNOTE-992 study of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with muscle-invasive bladder cancer (MIBC). J Clin Oncol 2024; 42(4_suppl): ts720. https:\/\/doi.org\/10.1200\/jco.2024.42.4_suppl.tps720","DOI":"10.1200\/JCO.2024.42.4_suppl.TPS720"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Suer E Hamidi N Gokce MI et al. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy. World J Urol 2016; 34(6): 847\u2013851. https:\/\/doi.org\/10.1007\/s00345-015-1710-5","DOI":"10.1007\/s00345-015-1710-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Grobet-Jeandin E Pinar U Parra J et al. Health-related quality of life after curative treatment for muscle-invasive bladder cancer. Nat Rev Urol 2023; 20(5): 279\u2013293. https:\/\/www.nature.com\/articles\/s41585-022-00693-z","DOI":"10.1038\/s41585-022-00693-z"},{"key":"e_1_3_2_13_2","unstructured":"Br\u00fcck K Atema V Leliveld AM et al. Health-related quality of life in patients treated for nonmetastatic muscle-invasive bladder cancer: radical cystectomy versus bladder-preserving therapy. Int J Radiat Oncol 2025; 123(4): 1004\u20131017. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625045092"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Gandi C Vaccarella L Bientinesi R et al. Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management. Urol J 2021; 88(2): 94\u2013102. https:\/\/doi.org\/10.1177\/0391560320987169","DOI":"10.1177\/0391560320987169"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Ploussard G Daneshmand S Efstathiou JA et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol 2014; 66(1): 120\u2013137. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814001675","DOI":"10.1016\/j.eururo.2014.02.038"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Sherry AD Stewart A Luo G et al. Intensity-modulated radiotherapy is superior to three-dimensional conformal radiotherapy in the trimodality management of muscle-invasive bladder cancer with daily cone beam computed tomography optimization. J Radiat Oncol 2019; 8(4): 395\u2013403. https:\/\/doi.org\/10.1007\/s13566-019-00411-0","DOI":"10.1007\/s13566-019-00411-0"},{"key":"e_1_3_2_17_2","unstructured":"Witjes JA Babjuk M Bellmunt J et al. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer\u2014an international collaborative multistakeholder effort. Eur Urol 2020; 77(2): 223\u2013250. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283819307638"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Bizzarri FP Campetella M Russo P et al. Risk factors for benign uretero-enteric anastomotic strictures after open radical cystectomy and ileal conduit. Urol J 2025; 92(2): 224\u2013230. https:\/\/doi.org\/10.1177\/03915603241303634","DOI":"10.1177\/03915603241303634"}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261445157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03915603261445157","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261445157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:32:06Z","timestamp":1789619526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03915603261445157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/03915603261445157"],"URL":"https:\/\/doi.org\/10.1177\/03915603261445157","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"value":"0391-5603","type":"print"},{"value":"1724-6075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}